Combinations for treating HIV infection

Details for Australian Patent Application No. 2005235116 (hide)

Owner Bristol-Myers Squibb Company

Inventors Yamanaka, Gregory; Nowicka-Sans, Beata; Lin, Pin-Fang

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005235116

PCT Pub. Number WO2005/102392

Priority 60/555,767 24.03.04 US

Filing date 1 March 2005

Wipo publication date 3 November 2005

Acceptance publication date 31 March 2011

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/522 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/102392 Priority application(s): WO2005/102392

31 March 2011 Application Accepted

  Published as AU-B-2005235116

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235121-Multi-portion endoluminal prosthesis

2005235111-Methods for controlling plant pathogens using N-phosphonomethylglycine